HALIX Appoints Richard van Rijnsoever as Vice President of Business Development and Project Management

Alex Huybens appointed as Chief Executive Officer (CEO) of HAL Allergy Holding B.V. and HALIX B.V.

Update On HALIX’s Commercial Manufacture Of COVID-19 Vaccine

HALIX facility approved for AstraZeneca’s COVID-19 vaccine active substance manufacturing

HALIX’s Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine

NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials

HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine

HALIX enters collaboration with the University of Oxford for GMP manufacturing of a COVID-19 vaccine

HALIX celebrates Grand Opening of its state-of-the-art cGMP facility

New cGMP facility starting operational production in Q4-2019